Pharmaco - Press Releases

Date	Title	Company
13-Dec-2019	Biofrontera AG: Christopher Pearson appointed new Chief Commercial Officer at US subsidiary Biofrontera Inc.	Biofrontera AG
13-Dec-2019	OXGENE™ announces year of continued growth and first licensing deals in Asia	OXGENE™
13-Dec-2019	All haemophilia A patients in Republic of Ireland get continued access to Sobi’s extended half-life factor replacement therapy	Sobi
13-Dec-2019	NICE AND THE SMC HAVE PUBLISHED RECOMMENDATIONS ON SHIONOGI’S MULPLEO® (LUSUTROMBOPAG), APPROVING ITS USE FOR THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING INVASIVE PROCEDURES	Shionogi & Co., Ltd
13-Dec-2019	Almirall and Iktos announce research collaboration in Artificial Intelligence for new drug design	Almirall, S.A. (ALM)
13-Dec-2019	Hansa Biopharma has agreed with the FDA on a regulatory path forward for imlifidase in kidney transplantation of highly sensitized patients in the U.S.	Hansa Biopharma
13-Dec-2019	CHMP Issues Positive Opinion to Expand CYRAMZA® (ramucirumab) Label to Include Results from RELAY Study in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer	Eli Lilly and Company
13-Dec-2019	Medication storage and dosage advice for parents	Valley Northern Limited
13-Dec-2019	4SC AG: Positive safety review of Phase Ib/II EMERGE study of domatinostat + avelumab in gastrointestinal cancer	4SC AG
12-Dec-2019	Mihael H. Polymeropoulos, MD, President and CEO of Vanda Pharmaceuticals Inc., to Receive The Physicians Committee for Responsible Medicine Trailblazer Award	Vanda Pharmaceuticals Inc.
12-Dec-2019	Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) in Infants With Cystic Fibrosis Ages 6 Months to Less Than 12 Months With Certain Mutations in the CFTR Gene	Vertex Pharmaceuticals
12-Dec-2019	MorphoSys AG: Corporate Calendar 2020 (news with additional features)	MorphoSys AG
12-Dec-2019	Release of results for the full fiscal year 2018/19 (ending 30 September 2019) on 18 December 2019	Douglas GmbH
12-Dec-2019	Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall XR(R)	Elite Pharmaceuticals, Inc.
12-Dec-2019	M1 Kliniken AG accelerates expansion in 2019: number of specialist centres increased by 50 percent to 36	M1 Kliniken AG
12-Dec-2019	B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG publishes preliminary results for the financial year 2018/19	B.R.A.I.N. Biotechnology Research And Information Network AG
12-Dec-2019	European Commission Approves EVENITY® (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture	Amgen
11-Dec-2019	Exclusive interview from HK Packaging Consulting speaker released for SMi’s Pre-Filled Syringes 2020 Conference	SMi Group
11-Dec-2019	Dr Samareh Lajaunias, Director at Combioxin Speaking at SMi's 22nd Annual Superbugs & Superdrugs Conference	SMi Group
11-Dec-2019	Invite from Lynne Ensor chair for Pharma Microbiology East Coast Conference, April 2020, Boston	SMi Group